Triplet versus doublet therapy in patients with metastatic hormone-sensitive prostate cancer.

Sci Rep · 2026 · PMC13125637 · PMID 41840025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

The triplet group demonstrated a favorable trend in PSA-PFS, PFS2, and OS; however, a statistically significant difference was observed only for PSA-PFS.

also in 1,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.